Molecular characterization, Antifungal susceptibility to fluconazole and Analysis of risk factors in patients with Candida auris blood stream infection from Tertiary Care Hospital in North India

Authors

  • Chitra Bhartiya Departments of Microbiology Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP
  • Rungmei SS Marak Departments of Microbiology Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP
  • RS Singh Emergency Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP
  • Pratima Rawat Departments of Microbiology Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP
  • Chinmoy Sahu Departments of Microbiology Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP
  • Ajai Kumar Dixit Departments of Microbiology Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP
  • Shikha Tripathi Departments of Microbiology Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, UP

DOI:

https://doi.org/10.31344/ijhhs.v7i700.537

Keywords:

Fungemia, Etest, drug resistance, PCR

Abstract

Aim and objectives: To analyse the risk factors, molecular characterization and detection of drug resistance to fluconazole in Candida auris candidemia.

Material and methods: BACTEC blood culture positive for candida on Gram stain from January 2017-December 2020 were inoculated on SDA plate and incubated for at 37ºC for the isolation of yeast colonies. The isolates were subjected to phenotypic identification, PCR and MALDI-TOF MS and antifungal susceptibility testing to fluconazole by Etest method. Demographic details of the patients were recorded and significant associated risk factors were analysed.

Results: A total of 59689 blood cultures were received during the study period from admitted patients. There was 623 episodes of candidemia during the study and 111 episodes was due to C. auris. Incidence of candidemia due to C. auris was 17%. The associated risk factors were diabetes mellitus (p <0.024), underlying respiratory illness (p <0.013), mechanical ventilation (p <0.009), dialysis (p <0.034), prolonged ICU stay (p <0.009), hypertension (p <0.035) and others included use of broad-spectrum antibiotics (94.5%) and steroids (23.4%). Only 9% (n=10) isolates were sensitive to fluconazole; 85.6% (n=95) were resistant and 5.4% (n=6) were sensitive dosedependent. Study showed mortality in 36%.

Conclusions: Emergence of Candida auris infection has caused a significant threat in patients admitted to the ICUs and is known to cause outbreaks in healthcare facilities. Strict precautions like barrier nursing, hand hygiene and proper infection control practices must be followed as well as use of appropriate antifungal therapy to prevent and control the spread of C. auris.

International Journal of Human and Health Sciences Supplementary Issue 02: 2023 Page: S34-S48

Downloads

Published

2023-05-30

How to Cite

Bhartiya, C., Marak, R. S., Singh, R., Rawat, P., Sahu, C., Dixit, A. K., & Tripathi, S. (2023). Molecular characterization, Antifungal susceptibility to fluconazole and Analysis of risk factors in patients with Candida auris blood stream infection from Tertiary Care Hospital in North India. International Journal of Human and Health Sciences (IJHHS), 7(700), S34-S48. https://doi.org/10.31344/ijhhs.v7i700.537

Issue

2023: Supplementary Issue-2: 2023

Section

Original Articles

License

Copyright (c) 2023 Chitra Bhartiya, Rungmei SS Marak, RS Singh, Pratima Rawat, Chinmoy Sahu, Ajai Kumar Dixit, Shikha Tripathi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the International Journal of Human and Health Sciences agree to the following terms that:

  1. Authors retain copyright and grant International Journal of Human and Health Sciences the right of first publication of the work.

  2. Creative Commons Licence
    Articles in International Journal of Human and Health Sciences are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.